These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 7693660

  • 1. The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand.
    Moustakas A, Lin HY, Henis YI, Plamondon J, O'Connor-McCourt MD, Lodish HF.
    J Biol Chem; 1993 Oct 25; 268(30):22215-8. PubMed ID: 7693660
    [Abstract] [Full Text] [Related]

  • 2. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands.
    Lin HY, Moustakas A, Knaus P, Wells RG, Henis YI, Lodish HF.
    J Biol Chem; 1995 Feb 10; 270(6):2747-54. PubMed ID: 7852346
    [Abstract] [Full Text] [Related]

  • 3. Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.
    Matsuzaki K, Kan M, McKeehan WL.
    In Vitro Cell Dev Biol Anim; 1996 Jun 10; 32(6):345-60. PubMed ID: 8842749
    [Abstract] [Full Text] [Related]

  • 4. The types II and III transforming growth factor-beta receptors form homo-oligomers.
    Henis YI, Moustakas A, Lin HY, Lodish HF.
    J Cell Biol; 1994 Jul 10; 126(1):139-54. PubMed ID: 8027173
    [Abstract] [Full Text] [Related]

  • 5. Homomeric interactions between type II transforming growth factor-beta receptors.
    Chen RH, Derynck R.
    J Biol Chem; 1994 Sep 09; 269(36):22868-74. PubMed ID: 7521335
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL, Benya PD, Padilla SR, Carbonaro-Hall D, Williams R, Buckley S, Warburton D.
    Biochem J; 1996 May 15; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
    De Crescenzo G, Pham PL, Durocher Y, O'Connor-McCourt MD.
    J Mol Biol; 2003 May 16; 328(5):1173-83. PubMed ID: 12729750
    [Abstract] [Full Text] [Related]

  • 8. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.
    Yamashita H, ten Dijke P, Franzén P, Miyazono K, Heldin CH.
    J Biol Chem; 1994 Aug 05; 269(31):20172-8. PubMed ID: 8051105
    [Abstract] [Full Text] [Related]

  • 9. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
    Rodriguez C, Chen F, Weinberg RA, Lodish HF.
    J Biol Chem; 1995 Jul 07; 270(27):15919-22. PubMed ID: 7608141
    [Abstract] [Full Text] [Related]

  • 10. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.
    Vivien D, Attisano L, Wrana JL, Massagué J.
    J Biol Chem; 1995 Mar 31; 270(13):7134-41. PubMed ID: 7706250
    [Abstract] [Full Text] [Related]

  • 11. Purification of a new type high molecular weight receptor (type V receptor) of transforming growth factor beta (TGF-beta) from bovine liver. Identification of the type V TGF-beta receptor in cultured cells.
    O'Grady P, Kuo MD, Baldassare JJ, Huang SS, Huang JS.
    J Biol Chem; 1991 May 05; 266(13):8583-9. PubMed ID: 1850748
    [Abstract] [Full Text] [Related]

  • 12. Heterodimeric transforming growth factor beta. Biological properties and interaction with three types of cell surface receptors.
    Cheifetz S, Bassols A, Stanley K, Ohta M, Greenberger J, Massagué J.
    J Biol Chem; 1988 Aug 05; 263(22):10783-9. PubMed ID: 2899081
    [Abstract] [Full Text] [Related]

  • 13. Ectodomain cleavage and shedding of the type III transforming growth factor-beta receptor in lung membranes effect of temperature, ligand binding and membrane solubilization.
    Philip A, Hannah R, O'connor-McCourt M.
    Eur J Biochem; 1999 May 05; 261(3):618-28. PubMed ID: 10215877
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
    Tam BY, Philip A.
    J Cell Physiol; 1998 Sep 05; 176(3):553-64. PubMed ID: 9699508
    [Abstract] [Full Text] [Related]

  • 15. Two novel patterns of transforming growth factor beta (TGF-beta) binding to cell surface proteins are dependent upon the binding of TGF-beta 1 and indicate a mechanism of positive cooperativity.
    Segarini PR, Ziman JM, Kane CJ, Dasch JR.
    J Biol Chem; 1992 Jan 15; 267(2):1048-53. PubMed ID: 1730634
    [Abstract] [Full Text] [Related]

  • 16. Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor.
    Whitson RH, Wong WL, Itakura K.
    J Cell Biochem; 1991 Sep 15; 47(1):31-42. PubMed ID: 1658013
    [Abstract] [Full Text] [Related]

  • 17. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
    Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H.
    J Biol Chem; 1996 Feb 02; 271(5):2769-75. PubMed ID: 8576253
    [Abstract] [Full Text] [Related]

  • 18. TGF-beta receptor expression on human keratinocytes: a 150 kDa GPI-anchored TGF-beta1 binding protein forms a heteromeric complex with type I and type II receptors.
    Tam BY, Germain L, Philip A.
    J Cell Biochem; 1998 Sep 15; 70(4):573-86. PubMed ID: 9712154
    [Abstract] [Full Text] [Related]

  • 19. Novel 150- and 180-kDa glycoproteins that bind transforming growth factor (TGF)-beta 1 but not TGF-beta 2 are present in several cell lines.
    MacKay K, Danielpour D.
    J Biol Chem; 1991 May 25; 266(15):9907-11. PubMed ID: 1851759
    [Abstract] [Full Text] [Related]

  • 20. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.
    Moustakas A, Takumi T, Lin HY, Lodish HF.
    J Biol Chem; 1995 Jan 13; 270(2):765-9. PubMed ID: 7822308
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.